Literature DB >> 26407386

The acute management of ST-segment-elevation myocardial infarction.

Serena F Carville1, Robert Henderson2, Huon Gray3.   

Abstract

Acute ST-segment-elevation myocardial infarction (STEMI) results from complete obstruction to coronary artery blood flow accompanied by the appearance of ST-segment-elevation on the electrocardiogram. Emergency treatment is required to restore coronary perfusion, thereby limiting the extent of damage to the myocardium and the likelihood of early death or future heart failure. This concise guideline summarises key recommendations from the National Institute for Health and Care Excellence clinical guideline on acute management of STEMI (CG167), of relevance to all healthcare professionals involved. Guidance is presented on choice of reperfusion strategies, procedural aspects, use of additional drugs before and alongside reperfusion therapies, and treatment of patients who are unconscious or in cardiogenic shock. © Royal College of Physicians 2015. All rights reserved.

Entities:  

Keywords:  STEMI; fibrinolysis; myocardial infarction; myocardial ischaemia; primary percutaneous coronary intervention; reperfusion; thrombolysis

Mesh:

Year:  2015        PMID: 26407386      PMCID: PMC4952799          DOI: 10.7861/clinmedicine.15-4-362

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  3 in total

Review 1.  The Effects of the SARS-CoV-2 Virus on the Cardiovascular System and Coagulation State Leading to Cardiovascular Diseases: A Narrative Review.

Authors:  Rafiq A Bhat; Syed Maqbool; Akanksha Rathi; Syed Manzoor Ali; Yoosuf Ali Ashraf Muhammad Hussenbocus; Xiao Wentao; Yongsheng Qu; You Zhang; Yuxiao Sun; Hai-Xia Fu; Ling Yun Wang; Atul Dwivedi; Javaid Akhter Bhat; Raja Saqib Iqbal; Md Monowarul Islam; Abhishek Tibrewal; Chuanyu Gao
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

2.  Clinical efficacy and safety of autologous stem cell transplantation for patients with ST-segment elevation myocardial infarction.

Authors:  Rong Li; Xiao-Ming Li; Jun-Rong Chen
Journal:  Ther Clin Risk Manag       Date:  2016-08-01       Impact factor: 2.423

3.  Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Min Li; Chengyu Li; Shiqi Chen; Yang Sun; Jiayuan Hu; Chen Zhao; Ruijin Qiu; Xiaoyu Zhang; Qin Zhang; Guihua Tian; Hongcai Shang
Journal:  Front Pharmacol       Date:  2018-08-03       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.